# US 2024/0398723 A1 · Method for manufacturing a medical patch for local and controlled release of bioactive substances for the treatment of chronic ulcers, and medical patch achieved with such method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0398723 A1
- Document ID: US20240398723A1
- Status: Published application
- Kind: A1
- Application number: 18/699,585
- Filed: 2022-10-07
- Published: 2024-12-05
- Earliest claimed: 2021-10-07
- Applicants: Consiglio Nazionale Delle Ricerche
- Inventors: SOLDANI Giorgio; Paola LOSI; Tamer ALKAYAL; llenia FOFFA; Aida CAVALLO; Marianna BUSCEMI
- Web page: https://patentgrep.com/patent/US20240398723A1

## CPC

- A61K 9/7023: {Transdermal patches and similar drug-containing composite devices, e.g. cataplasms (galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006)}
- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61K 35/19: Platelets; Megacaryocytes
- A61K 38/363: {Fibrinogen}
- A61K 38/4833: {Thrombin (3.4.21.5)}
- A61K 38/484: {Plasmin (3.4.21.7)}
- A61L 15/44: Medicaments
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/254: Enzymes, proenzymes
- A61L 2300/406: Antibiotics
- A61L 2300/41: Anti-inflammatory agents, e.g. NSAIDs
- B29C 41/085: {by rotating the former around its axis of symmetry}
- B29C 41/46: Heating or cooling
- B29K 2089/00: Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
- B29K 2105/0035: {Medical or pharmaceutical agents}
- B29L 2031/753: {Medical equipment; Accessories therefor (bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES

## Abstract

A method for manufacturing a medical patch for the treatment of chronic vascular and diabetic ulcers comprises the steps of preparing a tubular support, spraying toward the axial lateral surface of said support at least two separate, simultaneous, converging jets of two nebulized solutions containing fibrinogen and thrombin, respectively, rotating the support and/or orienting the jets in such a way as to deposit on said support a layer of material (M) of predetermined size, and incubating the material (M) until the fibrin contained therein is polymerized.

## Claims

### Claim 1

Method for manufacturing a medical patch for local and controlled release of bioactive substances for the treatment of ulcers, comprising the steps of:
a) providing a mandrel (10), in the form of a tubular support;
b) spraying towards the axial lateral surface of said mandrel (10) at least two separate, simultaneous and converging jets of a nebulized solution containing fibrinogen, and of a nebulized solution containing thrombin, respectively;
c) rotating the mandrel (10) around its own axis and/or orienting the aforementioned jets in such a way as to expose to said jets a predetermined circumferential portion of the axial lateral surface of said mandrel (10), until deposition on said circumferential portion of a layer of material (M) of predetermined dimensions;
d) incubating the material (M) until the fibrin contained therein is polymerized.

### Claim 2 (depends on 1)

Method according to claim 1, wherein step b) is carried out by spraying towards the axial lateral surface of the mandrel (10) a third separate jet, simultaneous and converging with respect to the other two jets, of a nebulized solution containing plasminogen (PLG) and/or platelet lysate (PL) and/or metalloprotease inhibitors and/or antibiotics and/or anti-inflammatories, and/or nanoparticles charged with active ingredients and/or nanovesicles secreted by cells and containing bioactive molecules.

### Claim 3 (depends on 2)

Method according to claim 2, wherein the platelet lysate (PL) is cord blood platelet lysate (CB-PL).

### Claim 4

Method according to any of the preceding claims, wherein the solution containing fibrinogen contains fibrinogen in a concentration ranging from 20 mg/ml to 100 mg/ml, and the solution containing thrombin contains thrombin in a concentration ranging from 500 IU/ml to 3500 IU/ml.

### Claim 5 (depends on 2, 3, 4)

Method according to any of claims 2 to 4, wherein the solution containing platelet lysate (PL) contains platelet lysate (PL) in a concentration ranging from 0.5×109 plt/ml to 10×109 plt/ml and the solution containing plasminogen (PLG) contains plasminogen (PLG) in a concentration ranging from 5 mg/ml to 100 mg/ml.

### Claim 6

Method according to any of the preceding claims, wherein step b) is carried out by means of dispensers (12), each adapted to spray a respective nebulized solution in the direction of the axial lateral surface of the mandrel (10).

### Claim 7 (depends on 6)

Method according to claim 6, wherein the nebulized solution containing fibrinogen is delivered from the respective dispenser (12) with a flow rate ranging from 0.1 ml/min to 0.4 ml/min, and the nebulized solution containing thrombin is delivered from the respective dispenser (12) with a flow rate ranging from 0.05 ml/min to 0.4 ml/min.

### Claim 8 (depends on 5, 6)

Method according to claim 5 or 6, wherein the nebulized solution containing platelet lysate (PL) and/or plasminogen (PLG) is delivered by the respective dispenser (12) with a flow rate ranging from 0.05 ml/min and 0.4 ml/min.

### Claim 9 (depends on 5, 6, 7, 8)

Method according to one of claims 5 to 8, wherein step c) is carried out by translating the dispensers (12) along a direction parallel to the axis of the mandrel (10) and/or by rotating the dispensers (12) around the mandrel axis (10).

### Claim 10

Method according to any of the preceding claims, wherein the diameter of the mandrel (10) is within a range of 3-10 cm, and/or the rotational speed of the mandrel (10) is within a range of 30-120 rpm, and/or the translation speed of the dispensers (12) along a direction parallel to the axis of the mandrel (10) is within a range of 10-50 cm/s, and/or the axial extension of the portion of the mandrel (10) struck by the superimposed jets is within a range of 2-20 cm, and/or the distance of the outlet orifice of the dispensers (12) from the axial lateral surface of the mandrel (10) is within a range of 2-6 cm, and/or the air supply pressure to the dispensers (12) to generate the jets is within a range of 8-16 psi.

### Claim 11

Method according to any of the preceding claims, comprising the step of freeze-drying the layer of material obtained in step d).

### Claim 12 (depends on 11)

Method according to claim 11, wherein the freeze-drying step is preceded by the step of fixing the layer of the material obtained in step d) on a plastic support, and by the step of freezing the assembly thus obtained at −50° for 30 min.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

Medical patch obtained according to the method of any of claims 1 to 12, for use in the therapeutic treatment of ulcers.

### Claim 14 (depends on 13)

Medical patch for use according to claim 13, wherein the ulcers are chronic vascular or diabetic ulcers.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

Medical patch obtained according to the method of any of claims 1 to 12, for use as a filler in the therapeutic treatment of tissue defects.

### Claim 16

Apparatus for manufacturing a medical patch, comprising:
a mandrel (10), in the form of a tubular support; and
a plurality of dispensers (12), each configured to deliver a nebulized solution in such a way that the outgoing jet strikes at least part of the axial lateral surface of said mandrel (10);
wherein the mandrel (10) is rotatable around its own axis, and/or the dispensers (12) are translatable along a direction parallel to the axis of the mandrel (10) and/or rotatable around the axis of the mandrel (10).

### Claim 17 (depends on 16)

Apparatus according to claim 16, wherein the dispensers (12) are each configured to deliver a flow rate of nebulized solution ranging from 0.05 ml/min to 0.4 ml/min.

### Claim 18 (depends on 16, 17)

Apparatus according to claim 16 or 17, wherein the diameter of the mandrel (10) is within a range of 3-10 cm, and/or the mandrel (10) is configured to rotate with a speed within a range of 30-120 rpm, and/or the dispensers (12) are configured to move along a direction parallel to the axis of the mandrel (10) with a speed within a range of 10-50 cm/s, and/or the dispensers (12) are configured to jointly strike with the respective jets a portion of the mandrel (10) having an axial extension within a range of 2-20 cm, and/or the distance of the outlet orifice of the dispensers (12) from the axial lateral surface of the mandrel (10) is within a range of 2-6 cm, and/or the dispensers (12) are configured to be supplied with air at a pressure within a range of 8-16 psi.
